N/A N=35 Digital Prehabilitation for Patients Undergoing Major Elective Surgery
Surgery
Primary: Number of Participants Recruited — 35 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=368 Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs
PreDiabetes · Hyperglycemia · Glucose, High Blood
Primary: Achievement of CDC's Benchmark for Type 2 Diabetes Risk Reduction as a Binary Outcome (Yes/no) — 58; 59 Participants — p=<0.05
N/A N=53 Impact of Music Improvisation Training on Cognitive Function in Older Adults
Aging · Cognitive Aging · Cognitive Impairment
Primary: Retention in Study — 22; 21 Participants
N/A N=19 Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
Type 1 Diabetes · Type 1 Diabetes Mellitus With Hypoglycemia · Hypoglycemia
Primary: The Change in Plasma Glucagon Levels (Pmol/L) Measured During Normoglycaemic and Hypoglycaemia — 1.34; 1.68; 2.26; 0.31 pmol/L — p=>0.99
Phase 2 N=74 Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
Hereditary Angioedema · Hereditary Angioedema Type I · Hereditary Angioedema Type II
Primary: Change of the 3-symptom Composite Visual Analogue Scale (VAS-3) Score From Pre-treatment to 4 Hours Post-treatment — -14.83; -13.10; -14.37; 1.92 Score on a scale — p=<…
Phase 3 N=3 Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
Binge-Eating Disorder · Obesity
Primary: Change in Binge-Eating Frequency — -14; -17.00 episodes per past 28 days
N/A N=20 Investigating Stimulation Parameter and Electrode Mode Changes on Speech Perception in Experienced Adult Cochlear Implant Recipients
Hearing Loss, Sensorineural
Primary: Paired Mean Difference Score for CNC Words Correct Between Default and LP1 MAPs in Quiet — -0.05 percentage word score
Phase 2 N=77 Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma · Plasma Cell Myeloma
Primary: Number of Days to Discharge — 11; 15 days — p=0.001
N/A N=102 Scotchbond Universal Plus Compared to Scotchbond Universal for Posterior Class I & II Restorations With Filtek Universal
Cavities of Teeth · Dental Decay
Primary: Retention of Restorative Material — 97; 100; 3; 0 percentage of restorations
N/A N=512 My Diabetes, My Community
Type 2 Diabetes
Primary: Mean Change in Percent of Hemoglobin A1C — -1.1; -0.8; -0.8 percentage of hemoglobin A1C — p=0.8
N/A N=49 Distribution and Randomization of Gun Safety Devices to Measure Uptake and Preferences
Gun Violence Prevention
Primary: Survey Response Rate — 23; 15; 14; 22 Participants
N/A N=19 Changes of Pain and Functional Parameters in Back Pain Patients Over Time
Changes Over Time in Pain and Functional Parameters
Primary: Changes in Visual Analog Scale Pain Scores — 3.6; 1.2; 0.5 Units on a scale
Phase 3 N=447 The Late Presenter Treatment Optimisation Study
HIV/AIDS
Primary: Treatment Failure — 49; 70; 48; 69 Participants
N/A N=100 HIV Self-testing With Online Supervision for Vietnamese MSM
HIV
Primary: HIV Self-testing With Online Supervision Past 6 Months at Baseline — 50; 44 Participants
Phase 2 N=97 A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
Corneal Edema · Corneal Endothelial Dysfunction
Primary: Percentage of Participants Achieving ≥15-letter Improvement in Best-corrected Visual Acuity (BCVA) at Month 6 - Imputed Data — 14.3; 44.4; 10.5; 36.8 Percentage of…